NSEOutcome of Board Meeting20 Aug 2026 · 20 Aug 2026, 04:56 pm
Outcome of Board Meeting
Rubfila International Limited · RUBFILA
✦ AI SummaryDivestiture
Rubfila International Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026, where the Board approved the proposed divestment of the Company's entire shareholding in Premier Tissues (India) Limited to M/s. Finquest Personal Care Pvt. Ltd. for an aggregate consideration of €61.00 crore, subject to shareholder and regulatory approvals.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rubfila International Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026.
Attachments (1)
📄pdf
Download →
RUBFILA_20082026165522_OUTCOME.pdf
View document text
RUBFILA
International Limited
RIL/SECTL/2026/
20-08-2026
National Stock Exchange of India Limited
BSE Limited
Phiroze Jeejeebhoy Towers Exchange plaza, Bandra Kurla Complex
Bandra (East)
Dalal Street
Mumbai-400051 .
Mumbai -400001
Scrip Code: 500367 Symbol: RUBFILA
Dear Sir / Madam,
Sub. : Outcome of the meeting of the Board of Directors of Rubfila lntemational Limited -
proposed divestment of the Company's entire shareholding in Premier Tissues (India)
Limited
Pursuant to Regulation 30 and other applicable provisions Of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations.), we wish to inform
you that the Board of Directors of Rubfila lntemational Limited ("Companyn or "RIL"), at its
meeting held on 20-08-2026, considered and approved -
1) To divest Company's entire shareholding !n Premier Tissues (India) Limited ("PTIL"), a
wholly owned subsidiary of the Company, to M/s.Flnquest Personal Care Pvt. (CIN
U20230MH2026PTC471920) Ltd ("Proposed Purchaser"), subject to receipt of the
requi;ite shareholder and other statutory or regulatory approvals.
Background and consideration by the Board
The Board had earlier appointed two independent registered valuers solely for the purpose of
obtaining a reliable valuation of the business of PTIL.
The Board deliberated on the various strategic options available in relation to PTIL, including a
partial divestment, demerger, induction Of a strategic partner and full divestment of the
Company's shareholding in PTIL.
Proposal recelved from the Proposed Purchaser
During the course of the meeting, Mr. Hardik Patel, Chairman of the Company, disclosed his
interest and informed the Board that M/s.Finquest Personal Care Pvt. (QIN
Registered office: 1ee53, NIDA. Meronpara Read, Kanjikode p.O., Palakkad -678 621. Kerala, Ind`fa. I page 1
Tel . +91 4912567261e4, Fax : col 491256726o
ema H. info@rubfila,com, ho@ri[bfila.co. in , rubfila@gmail.com, vebsife: \^Mw rubfila. com
CI N : L25199KL1993PLC007018
RUBFILA
filrB
International Limited
U20230lvIH2026PTC471920) was willing to acquire the Company's entire shareholding in PTIL
for an aggregate consideration of €61.00 crore.
The proposal is to acquire the shares on an "as is where is" basis, without undertaking any
further due diligence, and is subject to receipt of the requisite shareholder and other statutory or
regulatory approvals, as applicable.
The entire purchase consideration would be paid within 30 days from the date of receipt. of
shareholder approval or receipt Of the last applicable statutory or regulatory approval, whichever
is later.
Mr.Hardik a Patel, being an interested party recused himself from the deliberations of the
Board.
The Board noted, inter alia:
1. the valuation reports obtained from two independent registered valuers;
2. the aggregate consideration of € 61.00 crore offered by the Proposed Purchaser;
3. the Company's need to preserve and deploy its financial resources towards its core
rubber-thread bu§i ness;
4. the Proposed Purchaser's agreement to acquire the Compahy's entire shareholding in
PTIL on an "as is where is" basis, without any further due diligence;
5. the commitment to pay the entire purchase consideration within 30 days from the date of
receipt of shareholder approval or receipt of the last applicable statutory or regulatory
approval, whichever is later.
The Board also considered alternative price-discovery and transaction mechanisms, including
inviting offers from prospective purchasers through a public process and appointing investment
bankers to identify potential purchasers.
Having regard to the two independent valuation reports already obtained, the substantial and
immediate funding requirements of PTIL, the certainty of the offer, the absence of any further
due-diligence requirement and the time and costs associated with undertaking a fresh sale
process, the Board was unanimously of the view that timely and certain execution of the
proposed transaction would be in the best interests of the Company and its shareholders.
Accordingly, the Board approved the proposed divestment of the Company's entire
shareholding in PTIL to the Proposed Purchaser for an aggregate consideration of € 61.00
crore, subject to:
• receipt of the requisite approval of the shareholders of the company;
• receipt of all other applicable statutory and regulatory approvals;
• compliance with the Companies Act, 2013, the SEBI LODR Regulations and other
applicable laws; and
Registeredoffice.16/953. NIDA, Meronpera Road, Kanjikode p.O., PaLakkad-678621. Kerala, India. I page 2
Tel . +914912567261". Fax : not 4912567260
email. info@rubfila com. ho@rubfila.co in, rubfila@gmail.com, website: www. rubfila.cam
CIN : L25199KL1993PLC007018
RUBFILA
International Limited
• finalisation and execution of the necessary transaction documents reflecting the terms
approved by the Board.
The Board has authorised the Company Secretary and other designated officers of the
Company to undertake all necessary actions, including making the requisite disclosures to the
stock exchanges, obtaining the requisite shareholder and other applicable approvals, finalising
and executing the necessary transaction documents and ensuring compliance with all
applicable legal and regulatory requirements.
The details required pursuant to Regulation 30 of the SEBI LODR Regulations, read with the
applicable SEBl circulars, are enclosed as Annexure A.
2. To convene the 33rdAnnual General Meeting of the Members Of the Company on 29th
September, 2026 at 11.00 am.
The meeting Of the Board of Directors commenced at 3.00 p.in and concluded at 4-30 p.in
This disclosure is also being made available on the Company.'s website at www.rubfila,com
Kindly take the above information on record.
Thanking You,
Your Truly,
For Rubfila lntemational Limited
G. Krishna Kumar
Managing Director
DIN No.: 01450683
Registeied office: 16/953, NIDA, Menonpara F`oad. Kanjikode p.0.. Palakkad -678621. Kerala, lnd`fa. I page 3
Tel : +91491 2567261J34. Fax : +914912567260
email. `nfo@rubfila. com , ho@rubfila.co.in, rubfila@gmail.com; website: v`Miw. rubfiLa.com
CIN . L25199KL1993PLC007018
RUBFILA
ln(ernational Limited
ANNEXURE A
Details of the proposed divestment of PTIL
Particulars Disclosure
1, Entity whose sharesareproposedtobesold Premier Tissues (India) Limited.
2. Nature of the Sale of the Company's entire shareholding in PTIL, representing
proposed transaction 100% of PTIL's issued and paid-up equfty share capital, to
M/s.Finquest Personal Care Pvt. Ltd. (CIN
U20230MH2026PTC471920)
3. Contributlon during Turnover/revenue of PTIL for the financial year ended 31-03-2026
the last financial year : { 95.74 crore, representing 15.68 % of the consolidated
tumove[/revenue of the Company.
Net worth Of PTIL as at 31-03-2026 : {51.49 crore, representing
16.59 % of the consolidated net worth of the Company.
4. Expected date of The necessary transaction documents are expected to be
execution executed on or before 10-09-2026, subject to receipt of the
requisite approvals.
5. Expected date Of Within 30 days from the date of receipt of shareholder approval or
completlon receipt of the last applicable statutory or regulatory approval,
whichever is later, subject to fulfilment of the requirements
prescribed under applicable law.
6. Conslderation Aggregate cash consideration Of {61.00 crore for the Company's
entire shareholding in PTIL,
7. Basis of The consideration has been evaluated having regard to the
consideration valuation reports obtained from two independent registered
valuers.
8. Proposed Purchaser Name : M/s. M/s.Finquest Personal Care Pvt. Ltd. (CIN
U20230MH2026PTC471920)
Registered address : 602, Boston House, Suren Road,
Andheri East, Mumbai -400 093
Nature of business: Personal Care
Associated with promoter/promoter group : Yes
Registered office.16/953, NIDA, Meranpara Ftoad, Kanjikode p.O„ PaLakkad -678621. Kerala, India. I page 4
Tel . +914912567261J54, Fax : +914912567260
emaj'. inf
[Showing first 8,000 characters — download PDF for full document]